• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Use of a Prescription Drug-Monitoring Program by Emergency and Surgical Prescribers: Results of a Hospital Survey.急诊和外科处方医生对处方药监测程序的使用:一项医院调查的结果
HSS J. 2019 Feb;15(1):51-56. doi: 10.1007/s11420-018-9633-5. Epub 2018 Oct 17.
2
The current utilization and perceptions of prescription drug monitoring programs among emergency medicine providers in Florida.佛罗里达州急诊医学提供者对处方药监测计划的当前使用情况和看法。
Int J Emerg Med. 2017 Dec;10(1):16. doi: 10.1186/s12245-017-0140-0. Epub 2017 Apr 18.
3
Variations in prescription drug monitoring program use by prescriber specialty.不同专业医生对处方药物监测计划的使用情况存在差异。
J Subst Abuse Treat. 2018 Nov;94:35-40. doi: 10.1016/j.jsat.2018.08.006. Epub 2018 Aug 17.
4
The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.全州范围内的处方药物监测数据库与当前阿片类药物误用测量工具在识别已经使用阿片类药物的急诊科患者药物滥用行为方面的效用比较。
Am J Emerg Med. 2020 Mar;38(3):503-507. doi: 10.1016/j.ajem.2019.05.035. Epub 2019 May 17.
5
Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).医生对马里兰州处方药监测计划(PDMP)的态度和经历。
Addiction. 2017 Feb;112(2):311-319. doi: 10.1111/add.13620. Epub 2016 Nov 3.
6
Prescribing practices, knowledge, and use of prescription drug monitoring programs (PDMP) by a national sample of medical toxicologists, 2012.2012 年,全国范围内的医学毒理学家对处方药物监测计划(PDMP)的处方实践、知识和使用情况进行了调查。
J Med Toxicol. 2012 Dec;8(4):341-52. doi: 10.1007/s13181-012-0250-2.
7
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
8
How, why, and for whom do emergency medicine providers use prescription drug monitoring programs?急诊医学从业者如何、为何以及为谁使用处方药监测程序?
Pain Med. 2015 Jun;16(6):1122-31. doi: 10.1111/pme.12700. Epub 2015 Feb 17.
9
Physicians' Perspectives Regarding Prescription Drug Monitoring Program Use Within the Department of Veterans Affairs: a Multi-State Qualitative Study.医生对退伍军人事务部处方药物监测计划使用的看法:一项多州定性研究。
J Gen Intern Med. 2018 Aug;33(8):1253-1259. doi: 10.1007/s11606-018-4374-1. Epub 2018 Mar 8.
10
Prescription drug monitoring program use by opioid prescribers: a cross-sectional study.阿片类药物处方者对处方药监测计划的使用:一项横断面研究。
Health Aff Sch. 2023 Nov 30;1(6):qxad067. doi: 10.1093/haschl/qxad067. eCollection 2023 Dec.

引用本文的文献

1
Feasibility of implementing a screening tool for risk of opioid misuse in a trauma surgical population.在创伤外科人群中实施阿片类药物滥用风险筛查工具的可行性。
Implement Res Pract. 2024 Feb 2;5:26334895231226193. doi: 10.1177/26334895231226193. eCollection 2024 Jan-Dec.
2
The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.多因素方法应对阿片类药物危机中的处方药物监测计划:PDMP 数据,宾夕法尼亚州,2016-2020 年。
BMC Health Serv Res. 2023 Apr 13;23(1):364. doi: 10.1186/s12913-023-09272-3.
3
Improving Access to Evidence-Based Medical Treatment for Opioid Use Disorder: Strategies to Address Key Barriers within the Treatment System.改善阿片类物质使用障碍患者获得循证医学治疗的途径:应对治疗系统中关键障碍的策略
NAM Perspect. 2020 Apr 27;2020. doi: 10.31478/202004b. eCollection 2020.
4
Advances in prescription drug monitoring program research: a literature synthesis (June 2018 to December 2019).处方药物监测计划研究进展:文献综述(2018 年 6 月至 2019 年 12 月)。
Curr Opin Psychiatry. 2020 Jul;33(4):326-333. doi: 10.1097/YCO.0000000000000608.

本文引用的文献

1
Association Between Prescription Drug Monitoring Programs and Nonfatal and Fatal Drug Overdoses: A Systematic Review.处方药物监测项目与非致命性和致命性药物过量之间的关联:一项系统性综述。
Ann Intern Med. 2018 Jun 5;168(11):783-790. doi: 10.7326/M17-3074. Epub 2018 May 8.
2
Drug Overdose Deaths in the United States, 1999-2016.1999 - 2016年美国药物过量致死情况
NCHS Data Brief. 2017 Dec(294):1-8.
3
Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.州级处方药物监测计划(PDMP)要求与医生为非癌症慢性疼痛患者开具阿片类镇痛药处方模式之间的关联。
Addict Behav. 2018 Jan;76:348-354. doi: 10.1016/j.addbeh.2017.08.032. Epub 2017 Sep 5.
4
Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach.更安全、更恰当的阿片类药物处方开具:一个大型医疗系统的综合方法。
J Eval Clin Pract. 2017 Dec;23(6):1173-1179. doi: 10.1111/jep.12756. Epub 2017 Jul 14.
5
Prescription reporting with immediate medication utilization mapping (PRIMUM): development of an alert to improve narcotic prescribing.即时药物使用映射的处方报告(PRIMUM):开发一种改进麻醉处方的警报。
BMC Med Inform Decis Mak. 2016 Aug 22;16(1):111. doi: 10.1186/s12911-016-0352-x.
6
Impact of prescription drug-monitoring program on controlled substance prescribing in the ED.处方药监测计划对急诊科管制药品处方的影响。
Am J Emerg Med. 2015 Jun;33(6):781-5. doi: 10.1016/j.ajem.2015.03.036. Epub 2015 Mar 18.
7
Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access.大多数初级保健医生都知道处方药监测项目,但许多人发现这些数据难以获取。
Health Aff (Millwood). 2015 Mar;34(3):484-92. doi: 10.1377/hlthaff.2014.1085.
8
Prescription opioid analgesic use among adults: United States, 1999-2012.1999 - 2012年美国成年人处方阿片类镇痛药的使用情况
NCHS Data Brief. 2015 Feb(189):1-8.
9
Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.1999 - 2011年美国涉及阿片类镇痛药的药物中毒死亡情况
NCHS Data Brief. 2014 Sep(166):1-8.
10
A statewide prescription monitoring program affects emergency department prescribing behaviors.全州范围的处方监测计划影响急诊处方行为。
Ann Emerg Med. 2010 Jul;56(1):19-23.e1-3. doi: 10.1016/j.annemergmed.2009.12.011. Epub 2010 Jan 4.

急诊和外科处方医生对处方药监测程序的使用:一项医院调查的结果

Use of a Prescription Drug-Monitoring Program by Emergency and Surgical Prescribers: Results of a Hospital Survey.

作者信息

Leas Daniel, Seymour Rachel B, Wally Meghan K, Hsu Joseph R

机构信息

1Department of Orthopedic Surgery, Carolinas Trauma Network Research Center of Excellence, Carolinas HealthCare System, 1000 Blythe Boulevard, Charlotte, NC 28203 USA.

Charlotte, NC USA.

出版信息

HSS J. 2019 Feb;15(1):51-56. doi: 10.1007/s11420-018-9633-5. Epub 2018 Oct 17.

DOI:10.1007/s11420-018-9633-5
PMID:30863233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6384217/
Abstract

BACKGROUND

Drug overdoses are the leading cause of death due to injury in the USA. Currently, 49 states have prescription drug-monitoring programs (PDMPs) available to prescribers.

QUESTIONS/PURPOSES: We aimed to assess knowledge and practice of two groups of acute-care prescribers regarding controlled substances.

METHODS

A 16-question survey was distributed to a list of surgical and emergency medicine prescribers at our institution. The survey asked about prescriber demographics, previous experiences with a PDMP, and opinions about patient risk factors available within an electronic medical record (EMR).

RESULTS

We received 60 responses (27.1% response rate). All prescribers recognized a growing problem with opioids, both in general and in their own practices, with an average rating of 8.3/10 and 7.9/10, respectively. Although 95% were aware a PDMP was available, only 60% were registered users. Emergency medicine prescribers were significantly more likely to have registered and used the database; 52% said the PDMP was too time-consuming and 23% said the information was not easy to use. All respondents who reported PDMP use indicated it carried some clinical utility, with 87% reporting it to be "somewhat" or "very" useful. Emergency medicine prescribers were more likely to use the PDMP regularly, with 73% selecting "somewhat frequently" or higher, while only 9% of surgery prescribers indicated the same. Of all respondents, 97% agreed that an integrated alert in the existing EMR would be helpful.

CONCLUSION

Acute-care prescribers at our institution are universally aware of the opioid epidemic, but efficient and useful tools for identifying at-risk patients are lacking. Our prescribers desired an alert system integrated into the EMR to highlight targeted risk factors.

摘要

背景

药物过量是美国伤害致死的首要原因。目前,49个州为开处方者提供了处方药监测项目(PDMPs)。

问题/目的:我们旨在评估两组急性护理开处方者在管制药品方面的知识和实践情况。

方法

向我们机构的外科和急诊医学开处方者名单发放了一份包含16个问题的调查问卷。该问卷询问了开处方者的人口统计学信息、之前使用PDMP的经历以及对电子病历(EMR)中患者风险因素的看法。

结果

我们收到了60份回复(回复率为27.1%)。所有开处方者都认识到阿片类药物问题日益严重,无论是总体情况还是在他们自己的实践中,平均评分分别为8.3/10和7.9/10。尽管95%的人知道有PDMP可用,但只有60%是注册用户。急诊医学开处方者注册并使用该数据库的可能性显著更高;52%的人表示使用PDMP太耗时,23%的人表示信息不易使用。所有报告使用过PDMP的受访者都表示它具有一定的临床实用性,87%的人报告说它“有点”或“非常”有用。急诊医学开处方者更有可能经常使用PDMP,73%的人选择“有点频繁”或更高频率,而只有9%的外科开处方者表示同样情况。在所有受访者中,97%的人同意在现有的EMR中设置综合警报会有帮助。

结论

我们机构的急性护理开处方者普遍意识到阿片类药物流行问题,但缺乏识别高危患者的高效且有用的工具。我们的开处方者希望在EMR中集成一个警报系统,以突出针对性的风险因素。